26.10.2015 • NewsDede WillamsIndustrial gasesAir Products

Air Products-Pallas Seal Hydrogen Supply Deal

US industrial gases producer Air Products has signed a long-term hydrogen supply agreement with Pallas Nitrogen Texas to supply 44 million standard cbf/d of hydrogen from its existing Gulf Coast Pipeline (GCP) to the Dallas company’s production site at Pasadena, Texas.

Supply will begin in mid-2016 when Pallas starts up ammonia production operations at its new facility built on land leased from Air Products.

“This contract further loads our Gulf Coast hydrogen pipeline and network system, and at the same time makes use of some available land at our Pasadena plant, said Bill Hammarstrom, vice president, HyCO Americas at Air Products. The arrangement “illustrates our continuous improvement approach to optimize our capabilities and assets,” he added.

Hammarstrom said this agreement again demonstrates the value of the 600-mile GCP. Claimed to be the world’s largest hydrogen plant and pipeline network system, it stretches from the Houston Ship Channel in Texas to New Orleans, Louisiana, and supplies the gases producer’s customers with over 1.4 billion cbf/d of hydrogen from over 21 hydrogen production facilities.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.